Clodronic acid is a first-generation bisphosphonate used primarily to treat hypercalcemia of malignancy by inhibiting osteoclast-mediated bone resorption. As an analog of pyrophosphate, it binds to hydroxyapatite… Read more
Clodronic acid is a first-generation bisphosphonate used primarily to treat hypercalcemia of malignancy by inhibiting osteoclast-mediated bone resorption. As an analog of pyrophosphate, it binds to hydroxyapatite in bone tissue to prevent the release of calcium into the bloodstream. This category contains high-quality reference standards for clodronic acid, alongside its related compounds such as impurities and, where applicable, stable isotope labelled analogs. These materials are essential for pharmaceutical laboratories conducting rigorous impurity profiling and analytical method validation. By utilizing these characterized substances, researchers can ensure accurate identification and quantification of degradation products or synthetic by-products throughout the drug development process and quality control workflows. Maintaining access to these precise reference materials supports compliance with regulatory standards for purity and safety in bisphosphonate therapeutic applications.